A similar phenomenon was previously described in A549, a KRAS-mutant NSCLC cell line (in which ERK activation is CRAF-mediated as opposed to BRAF-mediation in V600E mutant cells) [40–42]. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.